Sirio Pharma (300791.SZ) issued 1.511 million restricted shares at a grant price of 13.27 yuan per share.

24/02/2025

GMT Eight

Sirio Pharma (300791.SZ) announced that on February 24, 2025, the company granted 1.511 million restricted stocks to the beneficiaries of the 2025 Restricted Stock Incentive Plan for the first time, with a grant price of 13.27 yuan per share.

DOGE layoffs "big knife" cuts towards NHTSA, Musk is about to rewrite autonomous driving rules?

CT Enterprise (03839) announced its annual performance, with a net profit attributable to shareholders of 11.168 million US dollars, an increase of 337.45% year-on-year.

Contact: contact@gmteight.com

Sirio Pharma (300791.SZ) issued 1.511 million restricted shares at a grant price of 13.27 yuan per share.

RECOMMEND

HK Stock Market Move | CGN MINING (01164) falls by more than 4% again, uranium prices are under pressure due to nuclear disarmament and the resumption of production at Inkai. Institutions say the market may have overreacted.

Soochow: The strong market of new shipbuilding is expected to continue in 2024, with Chinese shipyards establishing a turning point in profitability.

New share news | Chinese AI solution provider Wisdom Interconnection plans to list in Hong Kong, raising about $200 million.